Pigmentary skin disease
Conditions
Interventions
Gold Standard:Subjective evaluation score: The severity rating of patients with vitiligo is determined based on the Vitiligo Area Scoring Index (VASI) outlined in the "Consensus on the Diagnosis and T
Index test:Human hyperspectral imaging system (including SpectrAPP analysis software) and UV-MCF biological fluorescence hyperspectral imaging technology.
Sponsors
Yangzhou Hospital affiliated to Nanjing University of Chinese Medicine
Eligibility
Sex/Gender
All
Age
18 Years to 60 Years
Inclusion criteria
Inclusion criteria: 1.. Meet the diagnostic criteria for "vitiligo (refer to the 'Consensus on the Diagnosis and Treatment of Vitiligo (2021 Edition)')" / "chloasma (refer to the 'Consensus of Chinese Experts on the Diagnosis and Treatment of Chloasma (2021 Edition)')"; 2. Age 18~60 years old, gender is not limited; 3. Agree to participate in this study and sign the informed consent form; 4. Able to obey the arrangement and cooperate with experimental research
Exclusion criteria
Exclusion criteria: (1) There are skin breakage, dermatitis, eczema, acne, tattoos or other skin lesions in the area to be tested; (2) pregnant or lactating women; (3) Patients with serious underlying diseases or mental illness; (4) Patients with porphyria.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| colour of skin;Area of skin lesion;Accuracy;Sensitivity;Specificity; | — |
Countries
China
Contacts
Public ContactBai Shanshan
Yangzhou Hospital affiliated to Nanjing University of Chinese Medicine
Outcome results
None listed